{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:02:30Z","timestamp":1789542150252,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013669","name":"Ionis Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jacc.2022.01.010","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T15:53:01Z","timestamp":1646668381000},"page":"1023-1031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Key Questions About Familial\u00a0Hypercholesterolemia"],"prefix":"10.1016","volume":"79","author":[{"given":"Allan D.","family":"Sniderman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Glavinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Thanassoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2022.01.010_bib1","article-title":"Genetic basis of hypercholesterolemia in adults","volume":"6","author":"Saadatagah","year":"2021","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.jacc.2022.01.010_bib2","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jacc.2022.01.010_bib3","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1161\/ATVBAHA.120.315904","article-title":"Large-scale screening for monogenic and clinically defined familial hypercholesterolemia in Iceland","volume":"41","author":"Bjornsson","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2022.01.010_bib4","doi-asserted-by":"crossref","first-page":"aaf7000","DOI":"10.1126\/science.aaf7000","article-title":"Genetic identification of familial hypercholesterolemia within a single U.S. health care system","volume":"354","author":"Abul-Husn","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jacc.2022.01.010_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2013.04.011","article-title":"Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic","volume":"229","author":"Futema","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2022.01.010_bib6","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.01.010_bib7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.atherosclerosis.2021.01.008","article-title":"Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries","volume":"319","author":"Futema","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2022.01.010_bib8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S2213-8587(16)30041-9","article-title":"Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel","volume":"4","author":"Santos","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2022.01.010_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/aje\/155.6.487","article-title":"Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review","volume":"155","author":"Eichner","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2022.01.010_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00214181","article-title":"Evidence for a cholesterol-lowering gene in a French-Canadian kindred with familial hypercholesterolemia","volume":"96","author":"Sass","year":"1995","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacc.2022.01.010_bib11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/01.ATV.11.5.1137","article-title":"Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction","volume":"11","author":"Hopkins","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.jacc.2022.01.010_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.ATV.18.2.309","article-title":"Souich du C, Frohlich JJ, Hayden MR, Soutar AK. Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada","volume":"18","author":"Pimstone","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2022.01.010_bib13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/01.CIR.74.4.805","article-title":"Regulation of plasma levels of low-density lipoprotein cholesterol: interpretation of data on low-density lipoprotein turnover in man","volume":"74","author":"Meddings","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.01.010_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1042\/CS20090402","article-title":"Regulation of plasma LDL: the apoB paradigm","volume":"118","author":"Sniderman","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jacc.2022.01.010_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.ATV.3.1.40","article-title":"Overproduction of low density lipoproteins associated with coronary heart disease","volume":"3","author":"Kesaniemi","year":"1983","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.jacc.2022.01.010_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1161\/01.ATV.5.6.623","article-title":"Kinetic mechanisms determining variability in low density lipoprotein levels and rise with age","volume":"5","author":"Grundy","year":"1985","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.jacc.2022.01.010_bib17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1172\/JCI112360","article-title":"Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia","volume":"77","author":"Teng","year":"1986","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2022.01.010_bib18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0026-0495(86)90236-2","article-title":"Low density lipoprotein metabolism in familial combined hyperlipidemia and familial hypercholesterolemia: kinetic analysis using an integrated model","volume":"35","author":"Chait","year":"1986","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.jacc.2022.01.010_bib19","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/0026-0495(81)90064-0","article-title":"Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia","volume":"30","author":"Kissebah","year":"1981","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.jacc.2022.01.010_bib20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/BF01800473","article-title":"Familial combined hyperlipidaemia: use of stable isotopes to demonstrate overproduction of very low-density lipoprotein apolipoprotein B by the liver","volume":"14","author":"Cortner","year":"1991","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.jacc.2022.01.010_bib21","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/01.ATV.13.7.1110","article-title":"Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia","volume":"13","author":"Venkatesan","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.jacc.2022.01.010_bib22","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI107332","article-title":"Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia","volume":"52","author":"Goldstein","year":"1973","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2022.01.010_bib23","first-page":"224","article-title":"Familial combined hyperlipidemia: current knowledge, perspectives, and controversies","volume":"70","author":"Bello-Chavolla","year":"2018","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.jacc.2022.01.010_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-135-6-200109180-00014","article-title":"Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus","volume":"135","author":"Sniderman","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2022.01.010_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/01.ATV.14.4.501","article-title":"ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm","volume":"14","author":"Fisher","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.jacc.2022.01.010_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0022-2275(20)33899-2","article-title":"VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100","volume":"39","author":"Zulewski","year":"1998","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacc.2022.01.010_bib27","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1194\/jlr.M300448-JLR200","article-title":"Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation","volume":"45","author":"Tremblay","year":"2004","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacc.2022.01.010_bib28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.ATV.0000155323.18856.a2","article-title":"Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production","volume":"25","author":"Millar","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2022.01.010_bib29","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"clinical genetic testing for familial hypercholesterolemia: JACC Scientific Expert Panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.01.010_bib30","doi-asserted-by":"crossref","first-page":"100062","DOI":"10.1016\/j.jlr.2021.100062","article-title":"Lipoprotein metabolism in familial hypercholesterolemia","volume":"62","author":"Chemello","year":"2021","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacc.2022.01.010_bib31","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.01.010_bib32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jacl.2019.04.006","article-title":"LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia","volume":"13","author":"Paquette","year":"2019","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2022.01.010_bib33","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0140-6736(69)90930-1","article-title":"Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states","volume":"2","author":"Slack","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2022.01.010_bib34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.CIR.49.3.476","article-title":"Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia","volume":"49","author":"Stone","year":"1974","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.01.010_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCULATIONAHA.116.022335","article-title":"Long-term risk of atherosclerotic cardiovascular disease in US adults with the familial hypercholesterolemia phenotype","volume":"134","author":"Perak","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.01.010_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2013.12.020","article-title":"Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers","volume":"233","author":"Besseling","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2022.01.010_bib37","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/eurheartj\/ehx004","article-title":"Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia","volume":"38","author":"Tada","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.01.010_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacl.2015.09.003","article-title":"Premature coronary heart disease and autosomal dominant hypercholesterolemia: increased risk in women with LDLR mutations","volume":"10","author":"Ahmad","year":"2016","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacc.2022.01.010_bib39","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamacardio.2019.5954","article-title":"Association of monogenic vs polygenic hypercholesterolemia with risk of atherosclerotic cardiovascular disease","volume":"5","author":"Trinder","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2022.01.010_bib40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.atherosclerosis.2018.06.006","article-title":"Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia","volume":"277","author":"Futema","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2022.01.010_bib41","article-title":"Risk factors profile of young and older patients with myocardial infarction","author":"Sagris","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2022.01.010_bib42","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/eurheartj\/ehp051","article-title":"Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age)","volume":"30","author":"Wiesbauer","year":"2009","journal-title":"Eur Heart J"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722000742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722000742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:48:22Z","timestamp":1760017702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109722000742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0735109722000742"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2022.01.010","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Key Questions About Familial\u00a0Hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2022.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}